These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 12847397)
1. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide. Klinge JM; Topf HG; Trusen B; Rauh M; Rascher W; Dötsch J Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397 [TBL] [Abstract][Full Text] [Related]
2. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase. Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591 [TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide. Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190 [TBL] [Abstract][Full Text] [Related]
4. Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors. Kälvegren H; Andersson J; Grenegård M; Bengtsson T Eur J Pharmacol; 2007 Jul; 566(1-3):20-7. PubMed ID: 17459368 [TBL] [Abstract][Full Text] [Related]
5. Inhibition by nitric oxide-releasing compounds of prostacyclin production in human endothelial cells. Kosonen O; Kankaanranta H; Malo-Ranta U; Ristimäki A; Moilanen E Br J Pharmacol; 1998 Sep; 125(2):247-54. PubMed ID: 9786495 [TBL] [Abstract][Full Text] [Related]
6. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men. Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599 [TBL] [Abstract][Full Text] [Related]
7. Oxidized LDL and reduction of the antiaggregating activity of nitric oxide derived from endothelial cells. Minuz P; Lechi C; Gaino S; Bonapace S; Fontana L; Garbin U; Paluani F; Cominacini L; Zatti M; Lechi A Thromb Haemost; 1995 Oct; 74(4):1175-9. PubMed ID: 8560431 [TBL] [Abstract][Full Text] [Related]
9. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators. Salvemini D; Currie MG; Mollace V J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide. Martinez A; Salas E; Radomski A; Radomski MW Med Sci Monit; 2001; 7(4):646-51. PubMed ID: 11433190 [TBL] [Abstract][Full Text] [Related]
11. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors. Kobzar G; Mardla V; Samel N Platelets; 2011; 22(5):338-44. PubMed ID: 21557683 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin. Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511 [TBL] [Abstract][Full Text] [Related]
13. Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-rho kinase pathways. Nagaoka T; Hein TW; Yoshida A; Kuo L Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):825-32. PubMed ID: 17251484 [TBL] [Abstract][Full Text] [Related]
14. Nitric oxide mediates interactions between GABAA receptors and adenosine A1 receptors in the rat hippocampus. Fragata IR; Ribeiro JA; Sebastião AM Eur J Pharmacol; 2006 Aug; 543(1-3):32-9. PubMed ID: 16831416 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms. Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301 [TBL] [Abstract][Full Text] [Related]
16. The long-term exposure of endothelial cells to molsidomine increases their antithrombogenicity by inducing the production of nitric oxide-related chemical substances. Berenger-Bahuet FP; Rolland PH J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S98-105. PubMed ID: 2484710 [TBL] [Abstract][Full Text] [Related]
17. Regulatory role of nitric oxide over extracellular taurine in the hippocampus of freely moving rats. Watts J; Segieth J; Pearce B; Whitton PS Neurosci Lett; 2004 Mar; 357(3):179-82. PubMed ID: 15003279 [TBL] [Abstract][Full Text] [Related]
18. The calcium modulator nifedipine exerts its antiaggregatory property via a nitric oxide mediated process. Berkels R; Klaus W; Boller M; Rösen R Thromb Haemost; 1994 Aug; 72(2):309-12. PubMed ID: 7831670 [TBL] [Abstract][Full Text] [Related]
19. Nitric oxide inhibits migration of cultured endothelial cells. Lau YT; Ma WC Biochem Biophys Res Commun; 1996 Apr; 221(3):670-4. PubMed ID: 8630019 [TBL] [Abstract][Full Text] [Related]
20. The effect of streptozocin-induced diabetes on platelet aggregation as determined by impedance aggregometry and platelet secretion: a possible role for nitric oxide. Judge S; Mammen E; Dunbar JC J Assoc Acad Minor Phys; 1995; 6(3):100-4. PubMed ID: 7663098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]